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ARTICLE

Mice with a heterozygous Lrp6 deletion have impaired
fracture healing
Travis A Burgers1, Juan F Vivanco2, Juraj Zahatnansky1, Andrew J Vander Moren3, James J Mason1 and
Bart O Williams1
Bone fracture non-unions, the failure of a fracture to heal, occur in 10%–20% of fractures and are a costly and
debilitating clinical problem. The Wnt/β-catenin pathway is critical in bone development and fracture
healing. Polymorphisms of linking low-density lipoprotein receptor-related protein 6 (LRP6), a Wnt-binding
receptor, have been associated with decreased bone mineral density and fragility fractures, although this
remains controversial. Mice with a homozygous deletion of Lrp6 have severe skeletal abnormalities and are
not viable, whereas mice with a heterozygous deletion have a combinatory effect with Lrp5 to decrease bone
mineral density. As fracture healing closely models embryonic skeletal development, we investigated the
process of fracture healing in mice heterozygous for Lrp6 (Lrp6+/ − ) and hypothesized that the heterozygous
deletion of Lrp6 would impair fracture healing. Mid-diaphyseal femur fractures were induced in Lrp6+/ −
mice and wild-type controls (Lrp6+/+). Fractures were analyzed using micro-computed tomography (μCT)
scans, biomechanical testing, and histological analysis. Lrp6+/ − mice had signiﬁcantly decreased stiffness and
strength at 28 days post fracture (PF) and signiﬁcantly decreased BV/TV, total density, immature bone
density, and mature area within the callus on day-14 and -21 PF; they had signiﬁcantly increased empty callus
area at days 14 and 21 PF. Our results demonstrate that the heterozygous deletion of Lrp6 impairs fracture
healing, which suggests that Lrp6 has a role in fracture healing.
Bone Research (2016) 4, 16025; doi:10.1038/boneres.2016.25; published online: 6 September 2016

INTRODUCTION
The Wnt/β-catenin pathway is critical in bone development.1–2 The importance of this pathway to bone development was ﬁrst demonstrated with a report linking lowdensity lipoprotein receptor-related protein 5 (LRP5)
mutations and the pediatric syndrome, osteoporosis
pseudoglioma.3 Soon after, two studies showed that point
mutations in LRP5 cause increased bone mass.4–5 The
Wnt/β-catenin pathway is initiated when a Wnt protein that
binds to the complex that includes Lrp5, Lrp6, and Frizzled.6
Downstream, this allows β-catenin to avoid ubiquitindependent destruction that occurs through disheveled
and glycogen synthase kinase 3. Increased levels of
β-catenin cause nuclear translocation that causes TCF
(transcription factor)/LEF (lymphoid enhancer-binding
1

factor)- and TAZ (transcriptional coactivator with a PDZbinding domain)-mediated gene transcription.7–8
Polymorphisms of LRP6 have been associated with
decreased bone mineral density and fragility fractures,9–12
although others have not conﬁrmed the results.13–15 Mice
with a homozygous deletion of Lrp6 have severe skeletal
abnormalities and are not viable.16 Mice with heterozygous
Lrp6 deletion have a combinatory effect with Lrp5 to
decrease bone mineral density.17–18
Similar to embryonic skeletal development,19 fracture
repair utilizes regulated chondrogenic and osteoblastic
phases of bone formation: ﬁrst, inﬂammation; second,
cartilaginous callus formation; third, endochondral ossiﬁcation; and fourth, bone remodeling.20 A non-union occurs if
this process is disturbed and the fracture healing lasts
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longer or does not complete at all. Non-unions occur in
10%–20% of fractures21–22 and lead to increased treatment
costs and patient morbidity.23 The Wnt/β-catenin pathway
is also important in fracture healing.20,24–26 Mice with a
homozygous deletion of Lrp5 have impaired fracture
healing,27 whereas mice with a homozygous deletion of
secreted frizzled-related protein 1, a Wnt/β-catenin inhibitor, have improved fracture healing.28 To the authors’
knowledge, there have been no studies investigating the
role of Lrp6 in fracture healing.
Owing to the importance of the Wnt/β-catenin signaling
pathway, speciﬁcally LRP6, on bone development and the
importance of the Wnt/β-catenin signaling pathway in
fracture healing, we hypothesize that the heterozygous
deletion of Lrp6 will impair fracture healing.

MATERIALS AND METHODS
Animal model and specimen preparation
This study was approved by the Institutional Animal Care
and Use Committee at the Van Andel Research Institute
(Grand Rapids, MI, USA). Mice on a C57BL/6J background
with a heterozygous deletion of Lrp6 (Lrp6+/ − ) and wildtype control (Lrp6+/+) mice were previously generated.29 To
examine fracture healing and biomechanical characteristics, surgery was performed on approximately equivalent
numbers of male and female mice that were 11–12 weeks
old, and the right femur was fractured.
Each mouse was anesthetized using a subcutaneous
weight-matched dose of tribromoethanol (average 350 μL
dose of 0.079 mg · μL− 1 solution; Avertin; Winthrop Laboratories, New York, NY, USA). A 23-gauge needle was
surgically inserted in the femoral medullary canal of the
right femur and a femoral fracture was created at the
midshaft using a blunt impact force in a three-point
bending technique, following an established procedure.30
Pain was managed postoperatively with subcutaneous
doses of tramadol31 (20 mg·kg − 1; Sigma-Aldrich, St Louis,
MO, USA) administered at the time of surgery and at 12, 24,
and 36 h after fracture. Mice were killed at 7, 14, 21, and
28 days post fracture (PF). Mice were divided into one
group for biomechanical and micro-computed tomography (μCT) evaluation (n = 99) and one group for histological
evaluation (n = 45). For the biomechanical and μCT evaluation, 34 fractured femurs (from 16 Lrp6+/+ and 18 Lrp6+/ −
animals) were excluded because the fracture was oblique,
comminuted, or incomplete, as determined by follow-up
radiographs.32
Biomechanical evaluation
After killing of each animal for biomechanical and μCT
analyses, both the fractured and intact femurs were
excised and cleaned of the surrounding soft tissue. The
Bone Research (2016) 16025

intramedullary needle in the fractured femur was
removed and samples were stored at − 20 °C in salinesaturated gauze.
For biomechanical assessment of the bones, all femurs
were removed from the freezer, rehydrated in saline, and
allowed to equilibrate to room temperature. Four-point
bending mechanical testing was performed on the right
femur according to the same procedure as our previous
work.32 Force and displacement were directly measured
using the TestResources (TestResources, Shakopee, MN,
USA) system. Stiffness (deﬁned as the ratio between force
and displacement in the representative linear region) and
maximum strength (maximum load) were calculated in
Excel (Microsoft, Redmond, WA, USA). The coefﬁcient
of determination (R2) of the stiffness measure was
0.998 9 ± 0.001 5 (average ± s.d.). The stiffness ratio and
maximum load ratio were determined as the ratio of the
respective fractured femur property to the intact femur
property.

μCT evaluation
For μCT analysis, all femurs were scanned in saline by μCT
using a Skyscan 1172 high-resolution micro-CT (Skyscan,
Kontich, Belgium) with a voxel size of 13.3 μm. The two
Skyscan calibration phantoms were included in each scan.
Images were reconstructed using the Skyscan software.
Mimics 14.11 (Materialise, Ann Arbor, MI, USA) was used to
segment the phantoms and fracture calluses.32 The linear
relationship between the bone mineral content and
Hounsﬁeld units (HU)33–34 of each scan was calculated
using the known density of the two calibration phantoms
(0.25 and 0.75 g · cm− 3) and their segmented HU values.
In Mimics, two transverse slices were used to analyze the
bone maturity level of each callus (see Burgers et al.32 and
Collins et al.35 for similar examples). The center of the callus
was determined as the location of the small gap between
the bones. One slice each was used 0.5 mm proximal and
distal to the determined center.32 For each slice, four masks
were created. The ﬁrst mask included the total callus crosssectional area by differentiating the boundary of the callus
from the saline using the Mimics thresholding and “3D
LiveWire” tools. The second included only the mature area,
described by Komatsu et al.27 as that with a density greater
than 600 mg · cm − 3. The third included only the immature
bone area, described by Komatsu et al.27 as that with a
density of 250–600 mg · cm − 3. The fourth was the empty
(not mineralized) area with a density less than 250 mg · cm − 3.
The second through fourth masks were deﬁned using a
Boolean operation with the applicable thresholded density
range. The total, mature and immature densities of each
region were determined by calculating the mineral content
divided by the volume (area times slice thickness) of
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each mask. Mature bone volume over tissue volume
(BV/TV) was calculated as the ratio of the mature area to
the total area of the callus. Immature bone volume over
tissue volume (IV/TV) was calculated as the ratio of the
immature area to the total area of the callus.

Histological evaluation
For histological analysis, femurs were excised, the needle
was removed, and the sample was ﬁxed in 10% neutral
buffered formalin for at least 24 h, and decalciﬁed in 10%
EDTA, pH 7.5 for 5–8 days at room temperature. The samples
were embedded in parafﬁn along their long axis and
sectioned (5 μm). Before staining, slides were deparafﬁnized
and gradually rehydrated though series of ethanol washes.
Sections were stained for immunohistochemistry (IHC) and
tartrate-resistant acid phosphatase (TRAP). For IHC, in the
antigen-retrieval step, slides were incubated in pre-boiled
citrate buffer (#005001, Life Technologies, Grand Island, NY,
USA) for 10 min. Endogenous peroxidase activity was
quenched by 3% hydrogen peroxide for 30 min. The slides
were then incubated overnight with primary rabbit anti-βcatenin antibody (#9562, Cell Signaling, Danvers, MA, USA)
diluted 1:200. The secondary biotinylated goat anti-rabbit
antibody (#BA-1000, Vector Laboratories, Burlingame, CA,
USA) diluted 1:200 was used with the Vectastain avidin
biotinylated enzyme complex system for visualization. TRAP
staining for osteoclasts was performed using a Leukocyte
Acid Phosphatase Kit (#387A, Sigma-Aldrich) and counterstained with hematoxylin.

Statistical analyses
The effect of genotype was assessed statistically. Twotailed Student's t-tests were performed in Excel assuming

unequal variance between groups, and Po0.05 was
considered signiﬁcant. Average and s.d. are reported.

RESULTS
The stiffness and maximum strength (maximum load) were
measured in Lrp6+/ − and Lrp6+/+ femurs intact (Figure 1)
and during the process of fracture repair (Figure 2). There
was no signiﬁcant difference in the intact contralateral
bones from the Lrp6+/ − and Lrp6+/+ controls at any
time point.
As expected, the stiffness and strength increased throughout healing in both Lrp6+/ − and Lrp6+/+ groups (Figure 2).
Relative to Lrp6+/+ mice, Lrp6+/ − mice had signiﬁcantly
lower stiffness and maximum strength at 28 days PF. The
stiffness and maximum load in the Lrp6+/ − group were
decreased to 68 and 80% of the Lrp6+/+ group, respectively,
at day 28 PF.
At days 14 and 21 PF, the ratio of the biomechanical
properties (stiffness and maximum load) of the fractured to
intact limb was not signiﬁcantly different between the
Lrp6+/ − and Lrp6+/+ groups (Figure 3). At day 28 PF, the
stiffness ratio was not signiﬁcant between groups, but the
Lrp6+/ − had a signiﬁcantly lower maximum load ratio (75%
of the Lrp6+/+ group).
To gain further insight into how the heterozygous deletion
of Lrp6 inhibits the late decrease in biomechanical
characteristics of the healing bone, the μCT scans of the
calluses during healing were examined. At days 14 and 21
PF, the Lrp6+/ − group had signiﬁcantly less callus
BV/TV (53% and 74% that of the Lrp6+/+ group at days 14
and 21 PF, respectively) and IV/TV (72% and 82%,
respectively; Figure 4). The Lrp6+/ − group had signiﬁcantly
less total callus density (75% and 83%, respectively) at days
14 and 21 PF and less immature density at day 14 PF (93%);

Figure 1. Biomechanical measures of intact bone. There was no statistical difference in (a) stiffness and (b) maximum load in Lrp6+/ − and Lrp6+/+
controls at any time point. Error bars indicate one s.d. above the Lrp6+/+ group and one s.d. below the Lrp6+/ − group.
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Figure 2. Biomechanical measures of fractured femurs. There was a signiﬁcant decrease in the (a) stiffness and (b) maximum load at 28 days post
fracture (PF) in the Lrp6+/ − group. Error bars indicate one s.d. above the Lrp6+/+ group and one s.d. below the Lrp6+/ − group (*Po 0.05, Lrp6+/ −
and Lrp6+/+ at the time point).

Figure 3. Stiffness and maximum load ratios of fractured to intact femurs. There was no statistical difference in the (a) stiffness load ratio at any
time point. There was a signiﬁcant decrease in the (b) maximum load ratio at 28 days post fracture (PF) in the Lrp6+/ − group. Error bars indicate one
s.d. above the Lrp6+/+ group and one s.d. below the Lrp6+/ − group (*P o0.05, Lrp6+/ − and Lrp6+/+ at the time point).

Figure 4. Bone volume over tissue volume (BV/TV) and immature
bone volume over tissue volume (IV/TV) ratio for fracture callus. There
was a signiﬁcant decrease in BV/TV and IV/TV at days 14 and 21 post
fracture (PF) in the Lrp6+/ − group. Error bars indicate one s.d. above the
Lrp6+/+ group and one s.d. below the Lrp6+/ − group (*Po0.05, Lrp6+/ −
and Lrp6+/+ at the time point, and note that IV/TV signiﬁcance is
indicated below the data points).

Bone Research (2016) 16025

however, there was no signiﬁcant difference in mature
density at any time point (Figure 5). The Lrp6+/ − group
had signiﬁcantly less mature area (65% and 82%, respectively) at days 14 and 21 PF and signiﬁcantly more
empty area (198% and 139%, respectively) at days 14
and 21 PF (Figure 6). There was no signiﬁcant difference in
total callus area or immature area at any time point
(Figure 6).
To gain further insight into the biological differences within
the fracture calluses due to the heterozygous deletion of
Lrp6, IHC was performed. IHC sections showed no apparent
qualitative differences stained for Wnt signaling activity (βcatenin; Figure 7) or osteoclasts (TRAP; Figure 8) at any of
the three time points (day 21 PF not shown).

DISCUSSION
Relative to the Lrp6+/+ group, the Lrp6+/ − group had no
signiﬁcant difference in the stiffness and strength of intact
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Figure 5. Total callus density, mature callus density, and immature callus density in the fracture callus. There was a signiﬁcant decrease in (a) total
callus density at days 14 and 21 post fracture (PF) in the Lrp6+/ − group and in the (b) immature callus density at day 14 PF. There was no signiﬁcant
difference in the mature callus density at any time point. Error bars indicate one s.d. above the Lrp6+/+ group and one s.d. below the Lrp6+/ − group
(*P o0.05, Lrp6+/ − and Lrp6+/+ at the time point).

Figure 6. Total callus area, mature callus area, immature callus area, and empty callus area in the fracture callus. There was no statistical difference
in the (a) total area or immature area at any time point. There was a signiﬁcant increase in the (b) empty area and a signiﬁcant decrease in the (b)
mature area at days 14 and 21 post fracture (PF) in the Lrp6+/ − group. There was no statistical difference in total area or immature area at any time
point. Error bars indicate one s.d. above for the group with the larger area and one s.d. below for the group with the smaller area (*Po 0.05, Lrp6+/ −
and Lrp6+/+ at the time point).

bones at all time points. In a previous study investigating
limb development, the Lrp6+/ − group had signiﬁcantly
decreased trabecular BV/TV compared with the Lrp6+/+
group. Other bone characteristics were decreased but not
signiﬁcantly so.17 The mechanical characteristics are consistent with this result.
Biomechanical analysis also showed that Lrp6+/ − mice
had signiﬁcantly reduced stiffness and maximum strength
at day 28 PF in the fractured limb. They also had a
signiﬁcantly reduced maximum load ratio of the fractured
to intact limb at that time point. This difference later in the

healing process demonstrates that the heterozygous deletion of Lrp6 disrupts at least one stage of endochondral
ossiﬁcation. Fracture healing was also disrupted because
of the homozygous deletion of Lrp527 and the osteoblastspeciﬁc deletion of β-catenin.26 The results reported here
along with the previous literature demonstrate the importance of the role of Wnt signaling in the callus osteoblasts
and/or chondrocytes during fracture healing.
The μCT analysis showed that at days 14 and 21 PF, the
time in which chondrogenesis and endochondral ossiﬁcation is occurring,20 the Lrp6+/ − group had signiﬁcantly less
Bone Research (2016) 16025
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Figure 7. Representative β-catenin staining (for Wnt signaling activity, brown). There is similar β-catenin expression in the Lrp6+/ − group (left)
compared with the Lrp6+/+ controls (right) throughout healing (day 14 post fracture (PF), top; and day 28 PF, bottom, shown here).

Figure 8. Representative tartrate-resistant acid phosphatase (TRAP) staining (for osteoclasts, purple). There is similar TRAP expression in the
Lrp6+/ − group (left) compared with the Lrp6+/+ controls (right) throughout healing (day 14 post fracture (PF), top; and day 28 PF, bottom,
shown here).
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BV/TV, IV/TV, callus density, immature density (only day 14
PF), and mature area compared with the Lrp6+/+ group;
they also had signiﬁcantly more empty area. By day 28 PF,
there was no signiﬁcant difference in any of the μCT
analyses. The mature bone density decreased over time
because of the change of the structure of the callus.
Osteoclast activity along the original cortical bone is
intense around day 21 PF.36 As healing progresses, the
interior of the callus also loses its density as the mature bone
concentrates on the periosteal surface.35 The empty (not
mineralized) area in the callus was approximately doubled
in the Lrp6+/ − group at day 14 PF. This increase in the
empty area decreased the total callus density and BV/TV
in the Lrp6+/ − group. The empty areas that are not
mineralized are not completely empty as Figure 7 shows
that the callus contains numerous cells in the regions that
are not mineralized.
The mature density was likely not different between the
groups because there is little gradation in the tissue density
of mature bone.35 By day 14 PF, mature bone is distributed
around the outer portions of the callus,36 which is the most
biomechanically advantageous location.8,37 In intact bone
it is common that increased bone density leads to increased
stiffness and strength, but this is not necessarily the case for
fracture healing. It is most advantageous mechanically for
the healing bone to be mineralized farther away from the
longitudinal centerline of the bone.35,37 For example, during
the healing process mineralized callus close to the original
cortical bone may be mineralized, but at this location it
adds little strength in a bending test. As a result, the μCT
measures are useful in measuring some of the mineralization
processes of the callus but should be accompanied by
mechanical testing because they do not always correlate
with stiffness and strength. Because there was no signiﬁcant
difference in the stiffness and maximum load in the callus at
days 14 and 21 PF, the decrease in mature area suggests
that the mature bone may have been added preferentially
toward the inside of the callus.
Although the immature area was not different between
the groups, the immature density was decreased at day 14
PF and the IV/TV was decreased at days 14 and 21 PF in
the Lrp6+/ − group. This suggests that there was some
mineralization delay in the immature bone in mineralizing
at day 14 PF in the Lrp6+/ − group. This is consistent with a
recent study reporting that Lrp6 affects early osteogenic
differentiation.38 The area and density of the callus was not
different between the two groups in the late stages of
healing (day 28 PF), but the Lrp6+/ − group had signiﬁcantly
decreased stiffness, strength, and maximum load ratio. This,
along with the mineralization differences at days 14 and 21
PF, also may indicate that the callus mineralization was
more localized toward the inside of the callus where it is
not as biomechanically advantageous. To enhance the

understanding of the effect of Lrp6 on fracture healing,
future work using ﬁnite element analysis could be used to
investigate the distribution of mineral within the callus,39–41
and nano-indentation studies could be used to investigate
tissue-level or location-speciﬁc differences within the
callus.42–45
In a mouse model with a homozygous point mutation in
Lrp6 that results in decreased bone mass, lower bone mass
in the Lrp6 mutant mice was because of increased bone
resorption from increased osteoclast activity with no
change in bone formation.46 In an osteoblast-speciﬁc
Lrp6 knockout mouse model, lower bone mass was
because of decreased bone formation with no change
in osteoclast activity.38,47 In this study, the qualitative
appearance of the callus did not appear different
between the Lrp6+/ − and Lrp6+/+ groups in the IHC
staining. The progression of healing in the cartilaginous
callus followed the same pattern as that of bone built
during normal endochondral ossiﬁcation. The qualitative
similarities in β-catenin and TRAP staining indicated that
there was no marked difference in Wnt signaling activity or
osteoclast activity, respectively. It is possible that any
difference in biological activity that may have occurred
was muted because of only a single deleted allele of Lrp6.
The mechanical testing and μCT analyses from this study
demonstrate the importance of Lrp6 in fracture healing
and support the results of previous work on the importance
of Wnt signaling in fracture healing. As embryonic mice
with a homozygous Lrp6 mutation have severe skeletal
deformities,16 it is likely that an Lrp6 homozygous deletion
would amplify the fracture healing impairment compared
with that presented in this study. It is not possible to
investigate fracture healing in a total body homozygous
Lrp6 deletion because these mice are not viable; however,
further investigation into the effect of a homozygous
deletion could be investigated in a tissue-speciﬁc level
using conditional knockout mouse models using the
Cre-lox system (a bone- or cartilage-speciﬁc Cre model48
with an Lrp6ﬂ/ﬂ model, for example, refs 18,38,47,49). These
conditional knockout models could also be used to further
investigate whether Lrp6 impairs fracture healing due to
the chondrogenic response and/or the later osteoblastic
response.
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